The effect evaluation of Individual Placement and Support (IPS) for patients with substance use disorders: study protocol for a randomized controlled trial of IPS versus enhanced self-help

Eline Borger Rognli, Erlend Marius Aas, Robert E Drake, John Marsden, Paul Anders, Gary R Bond, June Ullevoldsæter Lystad, Silje Endresen Reme, Espen Ajo Arnevik, Eline Borger Rognli, Erlend Marius Aas, Robert E Drake, John Marsden, Paul Anders, Gary R Bond, June Ullevoldsæter Lystad, Silje Endresen Reme, Espen Ajo Arnevik

Abstract

Background: Employment is associated with better outcomes of substance use treatment and protects against relapse after treatment completion. Unemployment rates are high for people with substance use disorders (SUD) who undergo treatment, with Norwegian estimates ranging from 81 to 91%. Evidence-based vocational models are lacking for patients in SUD treatment but exist for patients with psychosis in terms of Individual Placement and Support (IPS). The aim of the IPS for substance use disorders (IPS-SUD) trial is to investigate the effect of IPS in a SUD population.

Methods/design: The IPS-SUD trial is a randomized controlled trial (RCT) comparing IPS to an enhanced control intervention. The study is a seven-site, two-arm, pragmatic, parallel-group, superiority RCT. Participants are randomly assigned (1:1) to receive either IPS plus treatment as usual (TAU) or to receive a self-help guide book and 12-h workshop plus 1-h individual vocational guidance plus TAU. Aiming to recruit 200 participants, we will be able to detect a 20% difference in the main outcome of employment with 90% power. We will make assessments at inclusion and at 6- and 12-month follow-ups and obtain outcome data on employment from national mandatory registries. The primary outcome will be at least 1 day of competitive employment during the 18-month follow-up period. Secondary employment outcomes will capture the pattern and extent of employment in terms of total time worked (days/hours), time to first employment, number of different jobs, duration of the longest employment, and sustained employment. Secondary non-employment outcomes will be substance use, mental distress, and quality of life measured by validated instruments at 6, 12, and 18 months follow-up assessments. To be eligible, participants must be between 18 and 65 years, currently unemployed and in treatment for SUD.

Discussion: The IPS-SUD trial will provide evidence for the use of IPS in a SUD population. Findings from the study will have implications for service delivery.

Trial registration: ClinicalTrials.gov NCT04289415 . Registered on February 28, 2020.

Keywords: Addiction; Dependence; Drugs; Employment support; IPS; Individual Placement and Support; Rehabilitation; SUD; Substance use disorders; Treatment.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Consolidated standards of reporting trials (CONSORT) flow of participants

References

    1. United Nations Office on Drugs and Crime. World Drug Report. 2018.
    1. Eastwood B, Strang J, Marsden J. Continuous opioid substitution treatment over five years: heroin use trajectories and outcomes. Drug Alcohol Depend. 2018;188:200–208. doi: 10.1016/j.drugalcdep.2018.03.052.
    1. Henkel D. Unemployment and substance use: a review of the literature (1990-2010) Curr Drug Abuse Rev. 2011;4(1):4–27. doi: 10.2174/1874473711104010004.
    1. Black CM. An independent review into the impact on employment outcomes of drug or alcohol addiction and obesity. Department for Work and Pensions; 2016. Report No.: 0101889828.
    1. Sherba RT, Coxe KA, Gersper BE, Linley JV. Employment services and substance abuse treatment. J Subst Abuse Treat. 2018;87:70–78. doi: 10.1016/j.jsat.2018.01.015.
    1. Brinchmann B, Widding-Havneraas T, Modini M, Rinaldi M, Moe CF, McDaid D, et al. A meta-regression of the impact of policy on the efficacy of Individual Placement and Support. Acta Psychiatrica Scandinavica. 2019, A meta‐regression of the impact of policy on the efficacy of individual placement and support.
    1. Drake RE, Bond GR, Becker DR. Individual placement and support: an evidence-based approach to supported employment. Oxford University Press; 2012.
    1. Modini M, Tan L, Brinchmann B, Wang M-J, Killackey E, Glozier N, Mykletun A, Harvey SB. Supported employment for people with severe mental illness: systematic review and meta-analysis of the international evidence. Br J Psychiatry. 2016;209(1):14–22. doi: 10.1192/bjp.bp.115.165092.
    1. Bond GR, Drake RE, Pogue JAJPs. Expanding individual placement and support to populations with conditions and disorders other than serious mental illness. Psychiatr Serv. 2019;70(6): 488-498, DOI: 10.1176/appi.ps.201800464.
    1. Lones CE, Bond GR, McGovern MP, Carr K, Leckron-Myers T, Hartnett T, et al. Individual placement and support (IPS) for methadone maintenance therapy patients: a pilot randomized controlled trial. Adm Policy Mental Health Ment Health Serv Res. 2017;44(3):359–364. doi: 10.1007/s10488-017-0793-2.
    1. LePage JP, Lewis AA, Crawford AM, Parish JA, Ottomanelli L, Washington EL, et al. Incorporating individualized placement and support principles into vocational rehabilitation for formerly incarcerated veterans. Psychiatr Serv. 2016;67(7):735–742. doi: 10.1176/appi.ps.201500058.
    1. Mueser KT, Campbell K, Drake RE. The effectiveness of supported employment in people with dual disorders. J Dual Diagn. 2011;7(1-2):90–102. doi: 10.1080/15504263.2011.568360.
    1. Marsden J, Anders P, Clark H, Colocassis K, Eastwood B, Knight J, Melaugh A, Quinn D, Wright V, Stannard J. Protocol for a multi-centre, definitive randomised controlled trial of the effectiveness of Individual Placement and Support for employment support among people with alcohol and drug dependence. Trials. 2020;21(1):1–12. doi: 10.1186/s13063-020-4099-4.
    1. OECD (2013). Mental health and work: Norway. OECD Publishing. 10.1787/9789264178984-en.
    1. NAV. Recipients of disability pensions according to diagnosis, age and gender ; 2015 [updated June 27th 2019.
    1. Abel KF, Skjærvø I, Ravndal E, Clausen T, Bramness JG. Perceived self-control is related to mental distress in patients entering substance use disorder treatment. Subst Use Misuse. 2018;53(9):1454–1462. doi: 10.1080/10826084.2017.1413114.
    1. Lauritzen G, Ravndal E, Larsson J. Gjennom 10 år. En oppfølgingsstudie av narkotikabrukere i behandling. Oslo: Statens Institutt for rusmiddelforskning; 2012.
    1. Waal H, Bussesund K, Clausen T, Lillevold PH, Skeie I. Statusrapport 2017. LAR 20 år. Status, vurderinger og perspektiver. Senter for rus- og avhengighetsforskning og Nasjonal kompetansetjeneste for tverrfaglig spesialisert rusbehandling; 2018.
    1. Velferdsetaten . Helhetlig russtatistikk Oslo kommune 2018/2019. Oslo: Velferdsetaten; 2019.
    1. Falkum E, Klungsøyr O, Lystad JU, Bull HC, Evensen S, Martinsen EW, Friis S, Ueland T. Vocational rehabilitation for adults with psychotic disorders in a Scandinavian welfare society. BMC Psychiatry. 2017;17(1):24. doi: 10.1186/s12888-016-1183-0.
    1. Reme SE, Monstad K, Fyhn T, Sveinsdottir V, Løvvik C, Lie SA, et al. A randomized controlled multicenter trial of individual placement and support for patients with moderate-to-severe mental illness. Scandinavian Journal of Work, Environment and Health. 2018, A randomized controlled multicenter trial of individual placement and support for patients with moderate-to-severe mental illness.
    1. Sveinsdottir V, Lie SA, Bond GR, Eriksen HR, Tveito TH, Grasdal A, Reme SE. Individual placement and support for young adults at risk of early work disability (the SEED trial). A randomized controlled trial. Scand J Work Environ Health. 2019;46(1):50–59. doi: 10.5271/sjweh.3837.
    1. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010;11(1):1–8. doi: 10.1186/1745-6215-11-32.
    1. Chan A-W, Tetzlaff JM, Altman DG, Dickersin K, Moher D. SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet. 2013;381(9861):91–92. doi: 10.1016/S0140-6736(12)62160-6.
    1. Forskrift om prioritering av helsetjenester, rett til nødvendig helsehjelp fra spesialisthelsetjenesten, rett til behandling i utlandet og om klagenemnd (prioriteringsforskriften), (2000). .
    1. Burns T, Yeeles K, Langford O, Montes MV, Burgess J. Anderson CJTBJoP. A randomised controlled trial of time-limited individual placement and support: IPS-LITE trial. Br J Psychiatry. 2015;207(4):351–356. doi: 10.1192/bjp.bp.114.152082.
    1. Bond GR, Peterson AE, Becker DR, Drake REJPS. Validation of the revised individual placement and support fidelity scale (IPS-25) Psychiatr Serv. 2012;63(8):758–763. doi: 10.1176/appi.ps.201100476.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Mykletun A, Stordal E, Dahl AA. Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry. 2001;179(6):540–544. doi: 10.1192/bjp.179.6.540.
    1. Kokkevi A, Hartgers C. EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res. 1995;1(4):208–210. doi: 10.1159/000259089.
    1. Lauritzen G, Ravndal E. Introduction of the EuropASI in Norway: Clinical and research experiences from a cost-effectiveness study. J Subst Use. 2004;9(3-4):141–146. doi: 10.1080/14659890410001697415.
    1. Mundt JC, Marks IM, Shear MK, Greist JM. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180(5):461–464. doi: 10.1192/bjp.180.5.461.
    1. Pedersen G, Kvarstein E, Wilberg T. health m. The Work and Social Adjustment Scale: Psychometric properties and validity among males and females, and outpatients with and without personality disorders. Pers Soc Psychol Bull. 2017;11(4):215–228. doi: 10.1002/pmh.1382.
    1. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72. doi: 10.1016/0168-8510(96)00822-6.
    1. Stavem K, Augestad LA, Kristiansen IS, Rand K. General population norms for the EQ-5D-3 L in Norway: comparison of postal and web surveys. Health Qual Life Outcomes. 2018;16(1):204. doi: 10.1186/s12955-018-1029-1.
    1. Bond GR, Campbell K, Drake RE. Standardizing measures in four domains of employment outcomes for individual placement and support. Psychiatr Serv. 2012;63(8):751–757. doi: 10.1176/appi.ps.201100270.
    1. Carpenter JR, Kenward MG. Missing data in randomised controlled trials: a practical guide. Birmingham, United Kingdom: National Institute for Health Research; 2007.
    1. Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials–a practical guide with flowcharts. BMC Med Res Methodol. 2017;17(1):1–10. doi: 10.1186/s12874-017-0442-1.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner